Pediatr. praxi. 2022;23(3):204-208 | DOI: 10.36290/ped.2022.044

Myocardial hypertrophy in a newborn from an unknown pregnancy

MUDr. Miroslava Burešová1, doc. MUDr. Jan Pavlíček, Ph.D.1, 2, MUDr. Magdalena Rohanová3
1 Oddělení dětské a prenatální kardiologie, Klinika dětského lékařství FN a LF OU Ostrava
2 Centrum biomedicínského výzkumu, FN Hradec Králové
3 Novorozenecká JIP, Pediatrická klinika, LF MU a FN Brno

The term myocardial hypertophy encompasses a wide range of pathologies. Most diseases in this group are serious, affecting the child's hemodynamics and clinical condition. However, there are also idiopathic or transient hypertrophies with good prognosis. This case report presents a transient myocardial hypertrophy in a newborn, probably caused by the premature arterial duct closure arising due to the use of non-steroidal anti-inflammatory drugs by the mother in the third trimester of cryptic pregnancy. The authors present an approach to the differential diagnosis of the myocardial hypertrophy in neonates and infants.

Keywords: cryptic pregnancy, hypertrophy, cardiomyopathy, ductus arteriosus.

Published: June 10, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Burešová M, Pavlíček J, Rohanová M. Myocardial hypertrophy in a newborn from an unknown pregnancy. Pediatr. praxi. 2022;23(3):204-208. doi: 10.36290/ped.2022.044.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Maron BJ, McKenna WJ, Danielson GK, et al. American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy. A report of the American College of Cardiology Foun­dation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. Eur Heart J. 2003;24:1965-1991. Go to original source... Go to PubMed...
    2. Stegeman R, Paauw ND, de Graaf R, et al. The etiology of cardiac hypertrophy in infants. Sci Rep. 2021;11(1):1-9. Go to original source... Go to PubMed...
    3. Zábrodská E. Vliv tlakového přetížení na vyvíjející se myokard. Available from: https://dspace.cuni.cz/handle/ 20.500.11956/106789.
    4. Moak JP, Kaski JP. Hypertrophic cardiomyopathy in children. Heart. 2012;98(14):1044-1054. Go to original source... Go to PubMed...
    5. Codazzi AC, Ippolito R, Novara C, et al. Hypertrophic cardiomyopathy in infant newborns of diabetic mother: a heterogeneous condition, the importance of anamnesis, physical examination and follow-up. Ital J Pediatr. 2021;47(1):1-6. Go to original source... Go to PubMed...
    6. Jenkins A, Millar S, Robins J. Denial of pregnancy-a literature review and discussion of ethical and legal issues. J R Soc Med. 2011;104:286-291. Go to original source... Go to PubMed...
    7. Kalkulátor echokardiografických parametrů u dětí. Available from: https://www.kardio-cz.cz/informace-pro-lekare-1091.
    8. Chaloupecký V, et al. Dětská kardiologie. Praha: Galén; 2006.
    9. Marek J. Pediatrická a prenatální kardiologie. Praha: Triton; 2003.
    10. Sharma D, Pandita A, Shastri S, Sharma P. Asymmetrical septal hypertrophy and hypertrophic cardiomyopathy in infant of diabetic mother: a reversible cardiomyopathy. Med J DY Patil Univ. 2016;9(2):257. Go to original source...
    11. Ullmo S, Vial Y, Di Bernardo S, et al. Pathologic ventricular hypertrophy in the offspring of diabetic mothers: a retrospective study. Eur Heart J. 2007;28(11):1319-1325. Go to original source... Go to PubMed...
    12. Colan SD, Lipshultz SE, Lowe AM, et al. Epidemiology and cause-specific outcome of hypertrophic cardiomyopathy in children: findings from the Pediatric Cardiomyopathy Registry. Circulation. 2007;115:773e81. Go to original source... Go to PubMed...
    13. Scaglia F, Towbin JA, Craigen WJ, et al. Clinical spectrum, morbidity, and mortality in 113 pediatric patients with mitochondrial disease. Pediatrics. 2004;114:925e31. Go to original source... Go to PubMed...
    14. Tartaglia M, Zampino G, Gelb BD. Noonan syndrome: clinical aspects and molecular pathogenesis. Mol Syndromol. 2010;1:2e26. Go to original source... Go to PubMed...
    15. Aoki Y, Niihori T, Inoue S, Matsubara Y. Recent advances in RASOpathies. J Hum genet. 2016;61:33-39. Go to original source... Go to PubMed...
    16. Cesar S. Neuromuscular diseases with hypertrophic cardiomyopathy. Glob Cardiol Sci Pract. 2018;12(3):27. Go to original source... Go to PubMed...
    17. Richard P, Charron P, Carrier L, et al. Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation. 2003;107:2227e32. Go to original source... Go to PubMed...
    18. Giri P, Roth P. Neonatal hypertension. Pediatr Rev. 2020;41(6):307-311. Go to original source... Go to PubMed...
    19. Patel N, Mills JF, Cheung MM. Use of the myocardial performance index to assess right ventricular function in infants with pulmonary hypertension. Pediatr Cardiol. 2009;30(2):133-137. Go to original source... Go to PubMed...
    20. Kwon EN, Kambalapalli M, Francis G, Donofrio MT. Fetal right-ventricular hypertrophy with pericardial effusion and maternal untreated hyperthyroidism. Pediatr Cardiol. 2013;34(8):2030-2033. Go to original source... Go to PubMed...
    21. Tomar M, Radhakrishnan S, Shrivastava S. Transient severe isolated right ventricular hypertrophy in neonates. Cardiol Young. 2003;13(4):384-386. Go to original source... Go to PubMed...
    22. Luchese S, Manica J, Zielinsky P. Intrauterine ductus arteriosus constriction. Analysis of a historic cohort of 20 cases. Arq Bras Cardiol. 2003;81:405-410. Go to original source... Go to PubMed...
    23. Gewillig M, Brown SC, De Catte L, et al. Premature foetal closure of the arterial duct: clinical presentations and outcome. Eur Heart Journal. 2009;30(12):1530-1536. Go to original source... Go to PubMed...
    24. Ishida H, Kawazu Y, Kayatani F, Inamura N. Prognostic factors of premature closure of the ductus arteriosus in utero: a systematic literature review. Cardiol Young. 2017;27:634-638. Go to original source... Go to PubMed...
    25. Mendl V, Biolek J, Jehlička P. Případ těžkého fetálního hydropsu na podkladě idiopatického interauterinního uzávěru tepenné dučeje. Čes-slov Pediat. 1999;5:208-210.
    26. Alvarez SG, McBrien A. Ductus arteriosus and fetal echocardiography: implications for practice. Semin Fetal Neonat M. 2018;23(4):285-291. Go to original source... Go to PubMed...
    27. Zielinsky P, Piccoli AL, Manica JLL, Nicoloso LHS. New insights on fetal ductal constriction: role of maternal ingestion of polyphenol-rich foods. Expert Rev Cardiovasc Ther. 2010;8(2):291-298. Go to original source... Go to PubMed...
    28. Koren G, Florescu A, Costei, A, et al. Nonsteroidal antiinflammatory drugs during third trimester and the risk of premature closure of the ductus arteriosus: a meta-analysis. Ann Pharmacother. 2006;40(5):824-829. Go to original source... Go to PubMed...
    29. Auer M, Brezinka C, Eller P, et al. Prenatal diagnosis of intrauterine premature closure of the ductus arteriosus following maternal diclofenac application. Ultrasound Obst Gyn. 2004;23(5):513-516. Go to original source... Go to PubMed...
    30. Ishima Y, Ishikawa H, Matsumura Y, et al. Idiopathic severe constriction of the fetal ductus arteriosus: a possible underestimated pathophysiology. Eur J Pediatr. 2000; 170(2):237-240. Go to original source... Go to PubMed...
    31. Soslow JH, Friedberg MK, Silverman NH. Idiopathic premature closure of the ductus arteriosus: an indication for early delivery. Echocardiography. 2008;25(6):650-652. Go to original source... Go to PubMed...

    Return to the content


    Pediatrics for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.